NCT04133545View on ClinicalTrials.gov

Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation

UnknownOBSERVATIONAL
Enrollment

360

Participants

Timeline

Start Date

April 4, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2020

Conditions
Auricular FibrillationAnticoagulant Drugs
Trial Locations (1)

C1199ABB

Hospital Italiano de Buenos Aires, Buenos Aires

Sponsors

Collaborators (1)

Boehringer Ingelheim
All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Hospital Italiano de Buenos Aires

OTHER

NCT04133545 - Discontinuation for Oral Anticoagulants in Patients With Atrial Fibrillation | Biotech Hunter | Biotech Hunter